InvestSMART

PharmX Technologies Limited (ASX: PHX) - Announcements

- Current share price for PHX : $0.069

ASX company news and announcements for PharmX Technologies Limited (PHX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmX Technologies Limited (PHX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmX Technologies Limited (PHX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmX Technologies Limited (PHX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$46 Initial Director's Interest Notice - M Conway 13 Mar 2026 11:52AM $0.110 $0.069 fallen by 37.27%
$46 Director Appointment 13 Mar 2026 11:50AM $0.110 $0.069 fallen by 37.27%
$46 Becoming a substantial holder 12 Mar 2026 10:59AM $0.110 $0.069 fallen by 37.27%
$46 Cleansing Notice 26 Feb 2026 4:31PM $0.125 $0.069 fallen by 44.80%
$46 Application for quotation of securities - PHX 26 Feb 2026 4:27PM $0.125 $0.069 fallen by 44.80%
$46 H1 FY26 Investor Presentation 25 Feb 2026 8:32AM $0.145 $0.069 fallen by 52.41%
$46 H1 FY26 Results Announcement 25 Feb 2026 8:27AM $0.145 $0.069 fallen by 52.41%
$46 Half Yearly Reports & Accounts 25 Feb 2026 8:26AM $0.145 $0.069 fallen by 52.41%
$46 Proposed issue of securities - PHX 23 Feb 2026 8:47AM $0.140 $0.069 fallen by 50.71%
$46 Pharmx and Sigma enter multi-year strategic alliance 23 Feb 2026 8:27AM $0.140 $0.069 fallen by 50.71%
$46 Notice of Results Announcement - 31 December 2025 4 Feb 2026 9:13AM $0.135 $0.069 fallen by 48.89%
$46 Results of Annual General Meeting 11 Nov 2025 11:52AM $0.150 $0.069 fallen by 54%
$46 Chairman's Address & CEO Presentation 11 Nov 2025 9:38AM $0.145 $0.069 fallen by 52.41%
$46 Pharmx launches new Marketplace platform 11 Nov 2025 8:26AM $0.145 $0.069 fallen by 52.41%
$46 Notice of Annual General Meeting & Proxy Form 10 Oct 2025 9:43AM $0.125 $0.069 fallen by 44.80%
$46 Update - Notification of cessation of securities - PHX 7 Oct 2025 4:23PM $0.130 $0.069 fallen by 46.92%
$46 Notification of cessation of securities - PHX 7 Oct 2025 4:17PM $0.130 $0.069 fallen by 46.92%
$46 Notification regarding unquoted securities - PHX 7 Oct 2025 4:15PM $0.130 $0.069 fallen by 46.92%
$46 Application for quotation of securities - PHX 7 Oct 2025 4:13PM $0.130 $0.069 fallen by 46.92%
$46 Update on Pharmacy Portal - StockView Feature Introduction 25 Sep 2025 9:25AM $0.138 $0.069 fallen by 49.82%
$46 2025 Annual General Meeting - Key Dates 12 Sep 2025 4:49PM $0.125 $0.069 fallen by 44.80%
$46 Initial Director's Interest Notice - A Mellis 1 Sep 2025 5:35PM $0.120 $0.069 fallen by 42.50%
$46 Final Director's Interest Notice - A Mellis 1 Sep 2025 5:35PM $0.120 $0.069 fallen by 42.50%
$46 Final Director's Interest Notice - D Bastas 1 Sep 2025 5:33PM $0.120 $0.069 fallen by 42.50%
$46 Director Changes & Office Address Update 1 Sep 2025 5:32PM $0.120 $0.069 fallen by 42.50%

26 - 50 of 111 results

Page 2 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.